Home
/
Records
/
Fda Inspections
/
Vitalant

FDA Inspection

•Vitalant•February 12, 2026

FDA Inspection 1303700 - Vitalant - February 12, 2026

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Record Details

This FDA Inspection record concerns Vitalant, with an inspection on February 12, 2026, issued by the Los Angeles District Office, covering biologics.

Company: Vitalant
Inspection Date: February 12, 2026
Product Type: Biologics
Office: Los Angeles District Office

Open in Dashboard

ID · 57f65b2c-79d0-4070-80f2-752cf0313124

Global Key Solutions

Regulatory Data Transformed

Contact

New York Office:

370 Jay Street 7th Floor

Brooklyn, NY 11201

Scranton Office:

Scranton Enterprise Center, Suite 217

201 Lackawanna Avenue

Scranton, PA, 18503

🇺🇸+1 917-789-5099

🇪🇺+48 532-447-507

[email protected]

Quick Links

KeyPedia™ Lite

Legal & Ethics

©2026, Global Key Solutions All rights reserved.

FDA Inspection 1303700 - Vitalant - February 12, 2026 | Global Key Solutions